| SEEL Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the SEEL shares outstanding history going back to 1/24/2019:
Also see: SEEL Market Cap History SEEL YTD Return |
SEEL Shares Outstanding History — Seelos Therapeutics Share Count Over Time
As of 8/6/2024 Seelos Therapeutics has 372306 SEEL shares outstanding. Investors often track the SEEL shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows SEEL share count trends over time, with 22 historical shares outstanding datapoints presented, dating back to 1/24/2019.
| SEEL Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||
SEEL Historical Shares Outstanding: +276.04% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||
| SEEL Stock Price Chart |
| About Seelos Therapeutics Inc |
| Seelos Therapeutics is a clinical-stage biopharmaceutical company focused on the development of products that address unmet needs in Central Nervous System disorders and other disorders. Co.'s primary programs are SLS-002 for the potential treatment of Acute Suicidal Ideation and Behavior in patients with Major Depressive Disorder and SLS-005 for the potential treatment of Amyotrophic Lateral Sclerosis and Spinocerebellar Ataxia. SLS-005 for the potential treatment of Sanfilippo Syndrome requires additional natural history data, which is being considered. Co. is also developing several preclinical programs, including SLS-004 and SLS-007, for the potential treatment of Parkinson's Disease. We show 22 historical shares outstanding datapoints in our coverage of SEEL's shares outstanding history. Understanding the changing numbers of SEEL shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like SEEL versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching SEEL by allowing them to research SEEL shares outstanding history as well as any other stock in our coverage universe. |
| SEEL Current Stock Quote |
Quotes delayed 20 minutes  Free SEEL Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| SEEL Share Performance |
| Shares Outstanding Peers |
| Seelos Therapeutics (SEEL) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
SEER Shares Outstanding History SELB Shares Outstanding History SEM Shares Outstanding History SENS Shares Outstanding History SERA Shares Outstanding History SESN Shares Outstanding History SGEN Shares Outstanding History SGFY Shares Outstanding History SGHT Shares Outstanding History SGMO Shares Outstanding History More Healthcare companies » |
SEEL Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
